"P.5.017 Use of valproate in treatment of behavioural and psychological disturbances of dementia" EUROPEAN NEUROPSYCHOPHARMACOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, AMSTERDAM, NL, vol. 15, 1 January 2005 (2005-01-01), page S565, XP025327109 ISSN: 0924-977X [retrieved on 2005-01-01] (B1)

CUMBO E ET AL: "Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease", EPILEPSY AND BEHAVIOR 2010 ACADEMIC PRESS INC. USA, vol. 17, no. 4, April 2010 (2010-04), pages 461-466, ISSN: 1525-5050 (B1)

EP-A- 1 731 149 (B1)

KOH MING TENG ET AL: "Treatment strategies targeting excess hippocampal activity benefit aged rats with cognitive impairment.", NEUROPSYCHOPHARMACOLOGY : OFFICIAL PUBLICATION OF THE AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY MAR 2010, vol. 35, no. 4, March 2010 (2010-03), pages 1016-1025, ISSN: 1740-634X (B1)

LIPPA CAROL ET AL: "Levetiracetam: Seizure management for elderly patients with cognitive impairment" NEUROLOGY, vol. 70, no. 11, Suppl. 1, March 2008 (2008-03), page A97, XP009127253 & 60TH ANNUAL MEETING OF THE AMERICAN-ACADEMY-OF-NEUROLOGY; CHICAGO, IL, USA; APRIL 12 -19, 2008 ISSN: 0028-3878 (B1)

MARINI G ET AL: "PLACEBO-CONTROLLED DOUBLE-BLIND STUDY OF PRAMIRACETAM CI-879 IN THE TREATMENT OF ELDERLY SUBJECTS WITH MEMORY IMPAIRMENT" ADVANCES IN THERAPY, vol. 9, no. 3, 1992, pages 136-146, XP009127252 ISSN: 0741-238X (B1)

WO-A-2009/109547 (B1)

US-A- 5 886 023 (B1)

US-A1- 2006 063 707 (B1)

US-A1- 2007 244 143 (B1)

US-A1- 2007 298 098 (B1)

US-A1- 2008 076 820 (B1)

ROZZINI R ET AL: "Treatment of cognitive impairment secondary to degenerative dementia. Effectiveness of oxiracetam therapy." ACTA NEUROLOGICA FEB 1993, vol. 15, no. 1, February 1993 (1993-02), pages 44-52, XP009127254 ISSN: 0001-6276 (B1)